Yorkshire health firm completes "major" multi-million pound facility expansion
A Yorkshire health company has announced that it has completed a “major” expansion of its test manufacturing facility.
Abingdon Health has expanded its York Biotech facility, meaning that the company now has the capacity to manufacture millions of rapid tests a month.
The expansion came in response to the Covid-19 pandemic, as the company developed antibody tests for the virus.
This is Abingdon Health’s third expansion at York Biotech Campus in the last year, as well as the addition of a manufacturing site in Doncaster, with an investment of £5.5m across the year.
Oliver Gardner, COO at Abingdon Health, commented: “The pandemic has raised awareness for the need for rapid testing across industries, not only for Covid-19.
“The demand for rapid tests will continue to grow across healthcare and areas such as crop production, animal health and farming.
“With the market set to exceed £9bn in the near future, we are well positioned to keep pace with demand.
“The new space at our York headquarters is a vital element in becoming one of the world’s leading rapid diagnostic manufacturers, helping more people every day to receive quick and accurate results.”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular Yorkshire & The Humber morning email for free.